Cited by 674Regulation of Appetite and ObesityGut microbiota and healthAdipose Tissue and Metabolism

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

Open access
Li, Zhuang, Yi, Chun-Xia, Katiraei, Saeed, Kooijman, Sander, Zhou, Enchen, Chung, Chih Kit, Gao, Yuanqing, van den Heuvel, José K +8 more·2018·Gut

Abstract

Objective: Butyrate exerts metabolic benefits in mice and humans, the underlying mechanisms being still unclear. We aimed to investigate the effect of butyrate on appetite and energy expenditure, and to what extent these two components contribute to the beneficial metabolic effects of butyrate. Design: Acute effects of butyrate on appetite and its method of action were investigated in mice following an intragastric gavage or intravenous injection of butyrate. To study the contribution of satiety to the metabolic benefits of butyrate, mice were fed a high-fat diet with butyrate, and an additional pair-fed group was included. Mechanistic involvement of the gut-brain neural circuit was investigated in vagotomised mice. Results: Acute oral, but not intravenous, butyrate administration decreased food intake, suppressed the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus, and decreased neuronal activity within the nucleus tractus solitarius and dorsal vagal complex in the brainstem. Chronic butyrate supplementation prevented diet-induced obesity, hyperinsulinaemia, hypertriglyceridaemia and hepatic steatosis, largely attributed to a reduction in food intake. Butyrate also modestly promoted fat oxidation and activated brown adipose tissue (BAT), evident from increased utilisation of plasma triglyceride-derived fatty acids. This effect was not due to the reduced food intake, but explained by an increased sympathetic outflow to BAT. Subdiaphragmatic vagotomy abolished the effects of butyrate on food intake as well as the stimulation of metabolic activity in BAT. Conclusion: Butyrate acts on the gut-brain neural circuit to improve energy metabolism via reducing energy intake and enhancing fat oxidation by activating BAT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2017-314050

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCFAs have an important role in the prevention and treatment of obesity-associated insulin resistance in animal studies.

    “Animal studies suggest that SCFAs have an important role in the prevention and treatment of obesity-associated insulin resistance (89, 114, 191, 192).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [89]

    The introduction says butyrate supplementation can prevent high-fat-diet-induced obesity and insulin resistance, and the results report lower insulin resistance in butyrate-treated mice. The discussion proposes butyrate as a strategy to combat obesity-related disease, but the study does not demonstrate treatment of established insulin resistance or the same benefit across SCFAs generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • SCFAs enhance sleep, suppress the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus, and modulate signaling triggered by the ghrelin receptor, contributing to circadian rhythm and appetite control.

    “Further, SCFAs show effects on several neural functions, such as enhancing sleep (10), suppressing the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus (89), and modulating the signaling triggered by the ghrelin receptor (129), contributing to circadian rhythm and appetite control.”
  • SCFAs are associated with a variety of diseases such as rectal cancer, pancreatitis, abnormal energy metabolism, constipation, blood lipid metabolism, sleep disorders and Alzheimer's disease.

    “Studies have found that SCFAs are associated with a variety of diseases such as rectal cancer, 174 pancreatitis, 175 abnormal energy metabolism, 176 constipation, 177 blood lipid metabolism, 178 sleep disorders 179 and Alzheimer's disease.180”
  • Activation of FFA3 receptors on vagus nerve cells can activate various CNS neurons, including dynamic regulation of hypothalamic neuronal circuitry.

    “Activation of FFA3 receptors on vagus nerve cells can result in the activation of various neurons in the CNS, including dynamic regulation of hypothalamic neuronal circuitry (287).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, Z., Yi, C.-X., Katiraei, S., Kooijman, S., Zhou, E., Chung, C. K., Gao, Y., van den Heuvel, J. K., Meijer, O. C., Berbée, J. F. P., Heijink, M., Giera, M., Willems van Dijk, K., Groen, A. K., Rensen, P. C. N., & Wang, Y.
Affiliations
  • Leiden University Medical Center (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
  • Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
  • University of Groningen (NL)
Corresponding author
Wang, Yanan
Venue
Gut
Publisher
BMJ
Published
2017-11-03
Volume
67
Issue
7
Pages
1269-1279
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2765733390
Cited by
674
References
48
Citations by year
2026: 50 · 2025: 107 · 2024: 101 · 2023: 95 · 2022: 102 · 2021: 82 · 2020: 65 · 2019: 50 · 2018: 19 · 2017: 1
FWCI
22.81
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
  • Universiteit Leiden
  • Leids Universitair Medisch Centrum
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
butyrate, appetite, brown adipose tissue, vagotomy, dietary intake, neuropeptide Y, hypothalamus, nucleus tractus solitarius, dorsal vagal complex, energy expenditure, fat oxidation, diet-induced obesity, hyperinsulinemia, hepatic steatosis, high-fat diet, sympathetic outflow, short-chain fatty acids
MeSH terms
Administration, Oral, Animals, Appetite, Adipose Tissue, Brown, Butyrates, Energy Intake, Energy Metabolism, Injections, Intravenous, Male, Satiety Response, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review